Connecticut 2019 Regular Session

Connecticut Senate Bill SB00975 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1
2	2
3	3	LCO No. 4705 1 of 5
4	4
5	5	General Assembly Raised Bill No. 975
6	6	January Session, 2019
7	7	LCO No. 4705
8	8
9	9
10	10	Referred to Committee on INSURANCE AND REAL ESTATE
11	11
12	12
13	13	Introduced by:
14	14	(INS)
15	15
16	16
17	17
18	18
19	19	AN ACT CONCERNING RE QUIRED HEALTH INSURANCE
20	20	COVERAGE FOR INFERTI LITY TREATMENT AND R EQUIRING THE
21	21	INSURANCE COMMISSION ER TO STUDY COVERAGE BARRIERS
22	22	POSED TO INDIVIDUALS WITH IATROGENIC INFERTILITY.
23	23	Be it enacted by the Senate and House of Representatives in General
24	24	Assembly convened:
25	25
26	26	Section 1. Subsection (b) of section 38a-509 of the general statutes is 1
27	27	repealed and the following is substituted in lieu thereof (Effective 2
28	28	January 1, 2020, and applicable to policies delivered, issued for delivery, 3
29	29	amended, renewed or continued on or after said date): 4
30	30	(b) Such policy may: 5
31	31	[(1) Limit such coverage to an individual until the date of such 6
32	32	individual's fortieth birthday;] 7
33	33	[(2)] (1) Limit such coverage for ovulation induction to a lifetime 8
34	34	maximum benefit of four cycles; 9
35	35	[(3)] (2) Limit such coverage for intrauterine insemination to a 10
36	36	lifetime maximum benefit of three cycles; 11 Raised Bill No. 975
37	37
38	38
39	39
40	40	LCO No. 4705 2 of 5
41	41
42	42	[(4)] (3) Limit lifetime benefits to a maximum of two cycles, with not 12
43	43	more than two embryo implantations per cycle, for in -vitro 13
44	44	fertilization, gamete intra-fallopian transfer, zygote intra-fallopian 14
45	45	transfer or low tubal ovum transfer, provided each such fertilization or 15
46	46	transfer shall be credited toward such maximum as one cycle; 16
47	47	[(5)] (4) Limit coverage for in-vitro fertilization, gamete intra-17
48	48	fallopian transfer, zygote intra-fallopian transfer and low tubal ovum 18
49	49	transfer to those individuals who have been unable to conceive or 19
50	50	produce conception or sustain a successful pregnancy through less 20
51	51	expensive and medically viable infertility treatment or procedures 21
52	52	covered under such policy. Nothing in this subdivision shall be 22
53	53	construed to deny the coverage required by this section to any 23
54	54	individual who foregoes a particular infertility treatment or procedure 24
55	55	if the individual's physician determines that such treatment or 25
56	56	procedure is likely to be unsuccessful; 26
57	57	[(6)] (5) Require that covered infertility treatment or procedures be 27
58	58	performed at facilities that conform to the standards and guidelines 28
59	59	developed by the American Society of Reproductive Medicine or the 29
60	60	Society of Reproductive Endocrinology and Infertility; 30
61	61	[(7)] (6) Limit coverage to individuals who have maintained 31
62	62	coverage under such policy for at least twelve months; and 32
63	63	[(8)] (7) Require disclosure by the individual seeking such coverage 33
64	64	to such individual's existing health insurance carrier of any previous 34
65	65	infertility treatment or procedures for which such individual received 35
66	66	coverage under a different health insurance policy. Such disclosure 36
67	67	shall be made on a form and in the manner prescribed by the 37
68	68	Insurance Commissioner. 38
69	69	Sec. 2. Subsection (b) of section 38a-536 of the general statutes is 39
70	70	repealed and the following is substituted in lieu thereof (Effective 40
71	71	January 1, 2020, and applicable to policies delivered, issued for delivery, 41
72	72	amended, renewed or continued on or after said date): 42 Raised Bill No. 975
73	73
74	74
75	75
76	76	LCO No. 4705 3 of 5
77	77
78	78	(b) Such policy may: 43
79	79	[(1) Limit such coverage to an individual until the date of such 44
80	80	individual's fortieth birthday;] 45
81	81	[(2)] (1) Limit such coverage for ovulation induction to a lifetime 46
82	82	maximum benefit of four cycles; 47
83	83	[(3)] (2) Limit such coverage for intrauterine insemination to a 48
84	84	lifetime maximum benefit of three cycles; 49
85	85	[(4)] (3) Limit lifetime benefits to a maximum of two cycles, with not 50
86	86	more than two embryo implantations per cycle, for in -vitro 51
87	87	fertilization, gamete intra-fallopian transfer, zygote intra-fallopian 52
88	88	transfer or low tubal ovum transfer, provided each such fertilization or 53
89	89	transfer shall be credited toward such maximum as one cycle; 54
90	90	[(5)] (4) Limit coverage for in-vitro fertilization, gamete intra-55
91	91	fallopian transfer, zygote intra-fallopian transfer and low tubal ovum 56
92	92	transfer to those individuals who have been unable to conceive or 57
93	93	produce conception or sustain a successful pregnancy through less 58
94	94	expensive and medically viable infertility treatment or procedures 59
95	95	covered under such policy. Nothing in this subdivision shall be 60
96	96	construed to deny the coverage required by this section to any 61
97	97	individual who foregoes a particular infertility treatment or procedure 62
98	98	if the individual's physician determines that such treatment or 63
99	99	procedure is likely to be unsuccessful; 64
100	100	[(6)] (5) Require that covered infertility treatment or procedures be 65
101	101	performed at facilities that conform to the standards and guidelines 66
102	102	developed by the American Society of Reproductive Medicine or the 67
103	103	Society of Reproductive Endocrinology and Infertility; 68
104	104	[(7)] (6) Limit coverage to individuals who have maintained 69
105	105	coverage under such policy for at least twelve months; and 70
106	106	[(8)] (7) Require disclosure by the individual seeking such coverage 71
107	107	to such individual's existing health insurance carrier of any previous 72 Raised Bill No. 975
108	108
109	109
110	110
111	111	LCO No. 4705 4 of 5
112	112
113	113	infertility treatment or procedures for which such individual received 73
114	114	coverage under a different health insurance policy. Such disclosure 74
115	115	shall be made on a form and in the manner prescribed by the 75
116	116	Insurance Commissioner. 76
117	117	Sec. 3. (NEW) (Effective from passage) (a) The Insurance 77
118	118	Commissioner shall conduct a study concerning the barriers posed to 78
119	119	individuals diagnosed with iatrogenic infertility for health insurance 79
120	120	coverage for fertility preservation and infertility treatments. 80
121	121	(b) Not later than January 1, 2020, the commissioner shall report the 81
122	122	results of the study, in accordance with section 11-4a of the general 82
123	123	statutes, to the joint standing committee of the General Assembly 83
124	124	having cognizance of matters relating to insurance. 84
125	125	This act shall take effect as follows and shall amend the following
126	126	sections:
127	127
128	128	Section 1 January 1, 2020, and
129	129	applicable to policies
130	130	delivered, issued for
131	131	delivery, amended,
132	132	renewed or continued on or
133	133	after said date
134	134	38a-509(b)
135	135	Sec. 2 January 1, 2020, and
136	136	applicable to policies
137	137	delivered, issued for
138	138	delivery, amended,
139	139	renewed or continued on or
140	140	after said date
141	141	38a-536(b)
142	142	Sec. 3 from passage New section
143	143
144	144
145	145
146	146	Statement of Purpose:
147	147	To: (1) Eliminate an age restriction concerning required health
148	148	insurance coverage for infertility treatment; and (2) require the Raised Bill No. 975
149	149
150	150
151	151
152	152	LCO No. 4705 5 of 5
153	153
154	154	Insurance Commissioner to conduct a study concerning coverage
155	155	barriers posed to individuals diagnosed with iatrogenic infertility.
156	156	[Proposed deletions are enclosed in brackets. Proposed additions are indicated by underline,
157	157	except that when the entire text of a bill or resolution or a section of a bill or resolution is new, it is
158	158	not underlined.]
159	159